ITMI913324A0 - Agenti farmaceutici - Google Patents
Agenti farmaceuticiInfo
- Publication number
- ITMI913324A0 ITMI913324A0 IT91MI3324A ITMI913324A ITMI913324A0 IT MI913324 A0 ITMI913324 A0 IT MI913324A0 IT 91MI3324 A IT91MI3324 A IT 91MI3324A IT MI913324 A ITMI913324 A IT MI913324A IT MI913324 A0 ITMI913324 A0 IT MI913324A0
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical agents
- pharmaceutical
- agents
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027014A GB9027014D0 (en) | 1990-12-12 | 1990-12-12 | Pharmaceutical agents |
GB919115107A GB9115107D0 (en) | 1991-07-12 | 1991-07-12 | Pharmaceutical agents |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI913324A0 true ITMI913324A0 (it) | 1991-12-11 |
ITMI913324A1 ITMI913324A1 (it) | 1993-06-11 |
IT1256282B IT1256282B (it) | 1995-11-29 |
Family
ID=26298105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI913324A IT1256282B (it) | 1990-12-12 | 1991-12-11 | Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica |
Country Status (30)
Country | Link |
---|---|
US (6) | US5319097A (it) |
EP (1) | EP0490648B1 (it) |
JP (1) | JP2585495B2 (it) |
KR (2) | KR0183027B1 (it) |
CN (2) | CN1043405C (it) |
AP (1) | AP285A (it) |
AT (1) | ATE131048T1 (it) |
AU (1) | AU656157B2 (it) |
BE (1) | BE1004229A5 (it) |
CA (2) | CA2319308C (it) |
CZ (1) | CZ283181B6 (it) |
DE (2) | DE69115229T2 (it) |
DK (1) | DK0490648T3 (it) |
ES (1) | ES2079589T3 (it) |
FI (1) | FI101193B1 (it) |
FR (1) | FR2670488B1 (it) |
GB (2) | GB2251791B (it) |
GR (1) | GR3018318T3 (it) |
HK (2) | HK81397A (it) |
HU (2) | HU213211B (it) |
IE (1) | IE75348B1 (it) |
IL (1) | IL100091A (it) |
IT (1) | IT1256282B (it) |
MX (1) | MX9102473A (it) |
MY (1) | MY106315A (it) |
NZ (1) | NZ240939A (it) |
PH (1) | PH30928A (it) |
RU (1) | RU2106140C1 (it) |
SK (2) | SK279813B6 (it) |
TW (1) | TW276181B (it) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole) |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
GR1001368B (el) * | 1992-10-08 | 1993-10-29 | Ici Plc | Φαρμακευτικοί φορείς. |
DE4235133A1 (de) * | 1992-10-19 | 1994-04-21 | Bayer Ag | Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid |
DE9410461U1 (de) * | 1994-07-01 | 1994-09-22 | Merck Patent Gmbh | Mittel für die Röntgenfluoreszenzanalyse |
US6279736B1 (en) | 1995-04-19 | 2001-08-28 | Capitol Specialty Plastics, Inc. | Barrier pack having an absorbing agent applied to the interior of the pack |
IN182496B (it) * | 1996-02-20 | 1999-04-17 | Reddy Research Foundation | |
US6630496B1 (en) | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
USRE43932E1 (en) | 1997-07-18 | 2013-01-15 | Novartis Ag | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
GB9723985D0 (en) | 1997-11-14 | 1998-01-14 | Zeneca Ltd | Pharmaceutical compositions |
GB9726735D0 (en) * | 1997-12-18 | 1998-02-18 | Zeneca Ltd | Pharmaceutical compositions |
US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
US6224907B1 (en) * | 1998-03-06 | 2001-05-01 | Alza Corporation | Anti-asthma therapy |
KR100283682B1 (ko) * | 1998-07-14 | 2001-03-02 | 조정래 | 열풍건조장치 |
US6253463B1 (en) | 1999-04-26 | 2001-07-03 | Niro A/S | Method of spray drying |
IN191496B (it) | 1999-07-30 | 2003-12-06 | Ranbaxy Lab Ltd | |
EP1216058A2 (en) * | 1999-09-20 | 2002-06-26 | Alza Corporation | Process for lessening polymorphic conversion of a drug |
IL139243A0 (en) * | 2000-10-24 | 2001-11-25 | Internat Specialty Products Is | Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof |
IL140096A0 (en) * | 2000-12-05 | 2002-02-10 | Internat Specialty Products Is | Process for preparation of zafirlukast |
US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
RS51449B (sr) * | 2001-01-26 | 2011-04-30 | Schering Corporation | Kombinacija aktivatora peroksizom proliferator-aktiviranog receptora (ppar) i inhibitora apsorpcije sterola i lečenje vaskularnih indikacija |
US20060287254A1 (en) * | 2001-01-26 | 2006-12-21 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
JP2005502628A (ja) * | 2001-07-10 | 2005-01-27 | ファルマシア・アンド・アップジョン・カンパニー | 結晶性チアジンオキサゾリジノン |
RS53251B (sr) * | 2001-08-15 | 2014-08-29 | Pharmacia & Upjohn Company Llc | Kristali koji sadrže n-[2-dietilamino)etil]-5-[(5-fluoro-2-okso-3h-indol-3-iliden)metil]-2,4-dimetil-1h-pirol-3- karboksamid so jabučne kiseline, procesi za njihovu pripremu i njihovi preparati |
DE60216300T2 (de) * | 2001-09-21 | 2007-06-28 | Schering Corp. | Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
AR040588A1 (es) * | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
US7459442B2 (en) * | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
JP5137228B2 (ja) * | 2003-03-07 | 2013-02-06 | メルク・シャープ・アンド・ドーム・コーポレーション | 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用 |
DE602004018617D1 (de) * | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US20050026882A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20090317476A1 (en) * | 2003-07-31 | 2009-12-24 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
US20050113410A1 (en) * | 2003-11-03 | 2005-05-26 | Mark Tawa | Pharmaceutical salts of zafirlukast |
ITMI20041032A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Compositi farmaceutici |
US20080254114A1 (en) * | 2005-03-03 | 2008-10-16 | Elan Corporation Plc | Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles |
US20070197467A1 (en) * | 2006-02-06 | 2007-08-23 | Srinivasulu Rangineni | Zafirlukast compositions |
US20090012146A1 (en) * | 2007-07-02 | 2009-01-08 | Giridhar Reddy Buggana | Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
EP2170825A2 (en) * | 2007-07-30 | 2010-04-07 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
US20090149662A1 (en) * | 2007-12-05 | 2009-06-11 | Raghupathi Reddy Anumula | Processes for preparing zafirlukast |
WO2014012954A1 (en) | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
WO2015110394A1 (en) | 2014-01-22 | 2015-07-30 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier) |
PT109030B (pt) | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
JP7272655B2 (ja) | 2017-01-30 | 2023-05-12 | ウェスタン ニュー イングランド ユニバーシティ | チオールイソメラーゼ阻害剤およびその使用 |
US10752585B2 (en) | 2017-12-28 | 2020-08-25 | Council Of Scientific & Industrial Research | Process for the preparation of Zafirlukast and analogs thereof |
EP4340828A1 (en) | 2021-05-19 | 2024-03-27 | Quercis Pharma AG | Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis |
WO2023214391A1 (en) | 2022-05-06 | 2023-11-09 | Quercis Pharma AG | Method for treating cancers and neurological diseases using quercetin-containing compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole) |
GB9027018D0 (en) * | 1990-12-12 | 1991-01-30 | Ici Plc | Heterocyclic compounds |
-
1991
- 1991-11-19 IL IL10009191A patent/IL100091A/en not_active IP Right Cessation
- 1991-11-22 CA CA002319308A patent/CA2319308C/en not_active Expired - Lifetime
- 1991-11-22 CA CA002056066A patent/CA2056066C/en not_active Expired - Lifetime
- 1991-12-09 HU HU913865A patent/HU213211B/hu unknown
- 1991-12-10 TW TW080109698A patent/TW276181B/zh not_active IP Right Cessation
- 1991-12-10 MX MX9102473A patent/MX9102473A/es unknown
- 1991-12-11 EP EP91311504A patent/EP0490648B1/en not_active Expired - Lifetime
- 1991-12-11 NZ NZ240939A patent/NZ240939A/en not_active IP Right Cessation
- 1991-12-11 CN CN91111566A patent/CN1043405C/zh not_active Expired - Lifetime
- 1991-12-11 FI FI915826A patent/FI101193B1/fi not_active IP Right Cessation
- 1991-12-11 GB GB9126354A patent/GB2251791B/en not_active Expired - Lifetime
- 1991-12-11 DE DE69115229T patent/DE69115229T2/de not_active Expired - Lifetime
- 1991-12-11 RU SU5010340/14A patent/RU2106140C1/ru active
- 1991-12-11 FR FR9115366A patent/FR2670488B1/fr not_active Expired - Fee Related
- 1991-12-11 AU AU88994/91A patent/AU656157B2/en not_active Expired
- 1991-12-11 IT ITMI913324A patent/IT1256282B/it active IP Right Grant
- 1991-12-11 AP APAP/P/1991/000340A patent/AP285A/en active
- 1991-12-11 JP JP3327783A patent/JP2585495B2/ja not_active Expired - Fee Related
- 1991-12-11 GB GB9418154A patent/GB2280606B/en not_active Expired - Lifetime
- 1991-12-11 CZ CS913756A patent/CZ283181B6/cs not_active IP Right Cessation
- 1991-12-11 AT AT91311504T patent/ATE131048T1/de not_active IP Right Cessation
- 1991-12-11 US US07/805,421 patent/US5319097A/en not_active Expired - Lifetime
- 1991-12-11 PH PH43619A patent/PH30928A/en unknown
- 1991-12-11 MY MYPI91002302A patent/MY106315A/en unknown
- 1991-12-11 BE BE9101127A patent/BE1004229A5/fr not_active IP Right Cessation
- 1991-12-11 IE IE431091A patent/IE75348B1/en not_active IP Right Cessation
- 1991-12-11 DE DE4140858A patent/DE4140858A1/de not_active Withdrawn
- 1991-12-11 ES ES91311504T patent/ES2079589T3/es not_active Expired - Lifetime
- 1991-12-11 SK SK3756-91A patent/SK279813B6/sk not_active IP Right Cessation
- 1991-12-11 KR KR1019910022917A patent/KR0183027B1/ko not_active IP Right Cessation
- 1991-12-11 DK DK91311504.4T patent/DK0490648T3/da active
-
1993
- 1993-09-03 US US08/116,781 patent/US5482963A/en not_active Expired - Lifetime
-
1995
- 1995-03-13 US US08/403,132 patent/US5504216A/en not_active Expired - Lifetime
- 1995-06-07 US US08/474,191 patent/US5612367A/en not_active Expired - Lifetime
- 1995-06-09 HU HU95P/P00181P patent/HU211126A9/hu unknown
- 1995-12-07 GR GR950403190T patent/GR3018318T3/el unknown
-
1996
- 1996-08-30 KR KR1019960036692A patent/KR100207802B1/ko not_active IP Right Cessation
-
1997
- 1997-06-19 HK HK81397A patent/HK81397A/xx not_active IP Right Cessation
- 1997-06-19 HK HK81597A patent/HK81597A/xx not_active IP Right Cessation
-
1998
- 1998-05-20 SK SK664-98A patent/SK279814B6/sk not_active IP Right Cessation
- 1998-07-13 US US09/114,225 patent/US5993859A/en not_active Expired - Lifetime
- 1998-10-14 CN CN98121369A patent/CN1105705C/zh not_active Expired - Lifetime
-
1999
- 1999-11-23 US US09/447,414 patent/US6143775A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI913324A0 (it) | Agenti farmaceutici | |
FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
FI922958A (fi) | Farmaceutisk sammansaettning | |
FI922252A (fi) | Farmaceutisk sammansaettning | |
FI922316A (fi) | Farmaceutisk sammansaettning | |
FI923581A (fi) | Farmaceutisk kombinationsformation | |
FI934914A (fi) | Farmaceutiska formuleringar | |
NO920067D0 (no) | Foradditiv for droevtyggere | |
NO923859D0 (no) | Medikament | |
ATE144765T1 (de) | Hiv-hemmende benzenacetamidderivate | |
ATE171449T1 (de) | Oxadolderivate | |
DK435688A (da) | Farmaceutiske midler | |
UA26064A1 (uk) | Фармацевтичhа композиція | |
FI930674A0 (fi) | Terapeutiska aemnen | |
DK0511991T3 (da) | Farmaceutisk formulering | |
NO306381B1 (no) | Farmasöytisk ampulle | |
FI931071A (fi) | Terapeutiska aemnen | |
ATA12390A (de) | Artikulator | |
NO923082L (no) | Terapeutiske midler | |
NO923037D0 (no) | Terapeutiske midler | |
FI971316A (fi) | Farmaseuttinen yhdiste | |
DK204190D0 (da) | Farmaceutisk praeparat | |
DK207590D0 (da) | Farmaceutisk praeparat | |
GB9027014D0 (en) | Pharmaceutical agents | |
IT221027Z2 (it) | Portaritratti perfezionato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |